Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APVO

Aptevo Therapeutics Inc

May 08 • 04:00PM ET

4.97

+0.11 2.26 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN SABS TNXP ONCO BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1779.06	Insider Own	0.06%	Shs Outstand	1.18M	Perf Week	1.02%
Market Cap	5.87M	Forward P/E	-	EPS next Y	-18.65	Insider Trans	-	Shs Float	1.18M	Perf Month	13.73%
Enterprise Value	-11.12M	PEG	-	EPS next Q	-5.60	Inst Own	3.83%	Short Float	8.83%	Perf Quarter	-25.82%
Income	-27.54M	P/S	-	EPS this Y	75.95%	Inst Trans	-0.22%	Short Ratio	1.94	Perf Half Y	-80.69%
Sales	0.00M	P/B	0.29	EPS next Y	11.15%	ROA	-125.94%	Short Interest	0.10M	Perf YTD	-47.30%
Book/sh	17.42	P/C	0.27	EPS next 5Y	40.87%	ROE	-247.98%	52W High	258.01 -98.07%	Perf Year	-96.17%
Cash/sh	18.31	P/FCF	-	EPS past 3/5Y	- 89.05%	ROIC	-129.81%	52W Low	3.80 30.79%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.52% 7.28%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	98.91%	Oper. Margin	-	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.82	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.09	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.82	EPS Q/Q	99.62%	SMA20	-1.80%	Beta	1.66	Target Price	21.00
Payout	-	Debt/Eq	0.27	Sales Q/Q	-	SMA50	-0.70%	Rel Volume	0.61	Prev Close	4.86
Employees	36	LT Debt/Eq	0.22	Earnings	Mar 26 BMO	SMA200	-73.63%	Avg Volume	53.61K	Price	4.97
IPO	Jul 20, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	28458.08% -	Trades		Volume	32,585	Change	2.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)